Gene: ZDHHC23
Official Full Name: zDHHC palmitoyltransferase 23provided by HGNC
Gene Summary: Predicted to enable protein-cysteine S-palmitoyltransferase activity. Involved in protein localization to plasma membrane and protein palmitoylation. Predicted to be located in Golgi membrane. Predicted to be active in Golgi apparatus and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21128 | ZDHHC23 Knockout cell line (HeLa) | Human | ZDHHC23 | 1:3~1:6 | Negative | Online Inquiry |
KO21129 | ZDHHC23 Knockout cell line (HCT 116) | Human | ZDHHC23 | 1:2~1:4 | Negative | Online Inquiry |
KO21130 | ZDHHC23 Knockout cell line (HEK293) | Human | ZDHHC23 | 1:3~1:6 | Negative | Online Inquiry |
KO21131 | ZDHHC23 Knockout cell line (A549) | Human | ZDHHC23 | 1:3~1:4 | Negative | Online Inquiry |
ZDHHC23 Gene Knockout Cell Lines are genetically modified cellular models that specifically have the ZDHHC23 gene disrupted. This gene is known to encode a palmitoyltransferase enzyme involved in post-translational modifications, particularly the palmitoylation of proteins, which regulates numerous cellular processes including signal transduction, protein localization, and stability. By employing CRISPR-Cas9 technology, these knockout cell lines disable the functional expression of the ZDHHC23 gene, allowing researchers to investigate the role of this gene in cellular pathways and disease mechanisms.
The primary function of ZDHHC23 involves its contribution to the palmitoylation cycle, a crucial modification that influences protein interactions and membrane localization. By using ZDHHC23 knockout cell lines, researchers can rigorously study how the absence of this gene affects cellular signaling pathways, particularly in the context of neurodevelopment, cancer, and other pathologies where palmitoylation plays a pivotal role.
Scientifically, these cell lines are invaluable tools for both fundamental and applied research. They enable detailed examination of the involvement of ZDHHC23 in various signaling networks and diseases, facilitating the discovery of novel therapeutic targets. Additionally, these models can be utilized in drug screening processes, offering insights into how the disruption of ZDHHC23 influences therapeutic responses.
Compared to alternative knockout models, ZDHHC23 Gene Knockout Cell Lines provide a streamlined approach for studying specific gene functions with precise alterations, leading to more accurate interpretations of experimental results. The specificity of this gene knockout mitigates potential off-target effects, thereby enhancing the reliability of data derived from experiments.
For researchers and clinicians alike, the availability of ZDHHC23 Gene Knockout Cell Lines offers a unique opportunity to deepen understanding of gene function and its implications in health and disease. This product is essential for those looking to push the boundaries of biological research and translation into clinical applications.
Our company prides itself on delivering high-quality genetic tools developed through rigorous scientific standards, ensuring robust support for your research endeavors. With expertise in molecular biology and cell line development, we are committed to empowering scientists with cutting-edge solutions that enhance knowledge across various biological fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.